Last reviewed · How we verify
NCT02552550
Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx
trial testing Ability to swallow, speak and quality of life in Squamous Cell Carcinoma of the Oropharynx in 12 participants. Terminated before completion.
20 September 2016
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Saint Etienne |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 12 |
| Start date | 25 July 2013 |
| Primary completion | 20 September 2016 |
| Estimated completion | 20 September 2016 |
| Sites | 1 location across France |
Drugs / interventions tested
- Ability to swallow, speak and quality of life
Conditions studied
- Squamous Cell Carcinoma of the Oropharynx — all drugs for Squamous Cell Carcinoma of the Oropharynx →
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Who can join
Adults 18 to 70, any sex, with Squamous Cell Carcinoma of the Oropharynx. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The curative treatment and organ preservation in advanced squamous cell carcinoma of the oropharynx is multimodal. It involves induction chemotherapy and depending on the response radio-chemotherapy or surgery. The combination of these methods has important functional consequences. The aim of this prospective pilot study is to describe swallowing, speech, but also patients' quality of life before and after therapeutic management (existing studies measuring these functions after treatment but not before).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02552550
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Squamous Cell Carcinoma of the Oropharynx
Currently open trials in the same condition.
- NCT05962242 — HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma · Phase 2 · recruiting
- NCT06061705 — Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive · NA · recruiting
- NCT05918510 — Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus · recruiting
- NCT04104945 — p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT) · NA · recruiting
- NCT04151134 — Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning · active not recruiting
Other Centre Hospitalier Universitaire de Saint Etienne trials
Trials by the same sponsor.
- NCT07326579 — Effects of a Sleep Education Program on the Health Status of Healthcare Workers Working 12-hour Alternating Day-night Sh · NA · not yet recruiting
- NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
- NCT07483710 — Association Between Muscle L3 CT Scan Muscle Derived Parameters of Muscle Function Upon Intensive Care Unit Admission an · NA · not yet recruiting
- NCT06845176 — Combining Motor Imagery and Tendon Vibration on the Effectiveness of Motor Imagery · NA · recruiting
- NCT07344298 — Less is Better? Effectiveness of a Short Local Vibration Protocol on Neuromuscular Function · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02552550 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Saint Etienne
- Last refreshed: 4 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02552550.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing